LloydsPharmacy is extending treatment options at its Scunthorpe Healthcare Centre to include a denosumab service for the prevention of fractures in patients that have cancer. This new cancer treatment pathway has been developed with Northern Lincolnshire and Goole NHS Foundation Trust (NLaG), building on existing breast cancer, respiratory and immunology services also delivered from the LloydsPharmacy clinic in Marsden Drive.
A specialist LloydsPharmacy Clinical Homecare (LPCH) oncology nurse delivers the subcutaneous injection which takes around 30 minutes plus an observation period to ensure that the patient has no adverse reactions. The nurse will discuss any side effects and symptoms prior to the administration of the treatment and advise on how best to manage these or refer back to their oncology team where appropriate.
Patients benefit from being able to receive their treatment closer to home without the stress and anxiety of car parking at the hospital. Suitable patients are identified by the oncology nursing team on the hospital ward who will have an initial discussion before referring them to the community service. The patient’s oncologist remains in charge of the process and the LPCH lead nurse has monthly updates with the hospital oncology team. As the injections are administered every four weeks and patients can be on the pathway for over a year, there can be considerable benefits for the hospital services and the patients.
David Willis, national speciality development manager at Celesio UK, says: “The launch of this new pathway is a another step forward in offering patients easier and more convenient access to receive their treatment while supporting busy speciality teams in the hospital. This innovative new pathway will mean that patients can have up to 12 fewer hospital trips a year while managing their treatment. Patients can find themselves on this treatment for a very long time and this pathway means that there is less disruption to their lives while managing their health. The positive patient feedback we are receiving supports the on-going demand to explore more and more pathways.”
Paulash Haider, Assistant Chief Pharmacist (Business Development) at Northern Lincolnshire and Goole NHS Foundation Trust, says: “The community clinic developed in partnership with Celesio offers greater patient choice and feedback from patients using the service has been 100% positive. We continue to work with LloydsPharmacy to develop more clinical pathways for other medicines to enable more patients to benefit from this innovative community service”.